Rapid screening for modes-of-action of M. tuberculosis inhibitors by high-throughput metabolic fingerprinting

Medicine & Life Sciences

1. Drug Discovery 100%
2. Mycobacterium tuberculosis 94%
3. Tuberculosis 73%
4. Libraries 57%
5. Genome 43%
6. Growth Inhibitors 42%
7. Metabolome 36%
8. Metabolomics 35%
9. Microbial Drug Resistance 32%
10. Proteomics 29%
11. Communicable Diseases 27%
12. Anti-Bacterial Agents 21%
13. Technology 21%
14. Growth 16%
15. In Vitro Techniques 14%
16. Therapeutics 5%